PEG-PEI/siROCK2 inhibits Aβ42-induced microglial inflammation via NLRP3/caspase 1 pathway

Abstract

ObjectivesThere is an urgent need to develop therapeutic strategies to improve the treatment outcome of Alzheimer's disease. The treatment strategy of gene therapy mediated by nanocarrier systems brings new hope for the treatment of Alzheimer's disease. ROCK2 is involved in various pathological processes of Alzheimer's disease and may be a potential target for the treatment of Alzheimer's disease. Our previous study indicated that PEG-PEI/siROCK2 [polyethyleneglycol-polyethyleneimine deliver ROCK2-siRNA, (PPSR)] prevented Aβ 42 -induced neurotoxicity and showed a promising prospect for the treatment of Alzheimer's disease. However, whether PPSR has an effect on the microglial inflammation in Alzheimer's disease is still unclear.Materials and methods 3-(4, 5-dimethylthiazol-2-yl)-2, 5-diphenyltetrazolium bromide assay was used to detect the cytotoxicity of PEG-PEI and PPSR in primary microglial cells. Real-time PCR and western blotting were used to assess the expression of ROCK2 and nucleotide oligomerization domain-like receptor family pyrin domain containing 3 (NLRP3)/caspase 1 pathway in primary microglial cells. ELISA assay was used to measure the effect of PPSR on attenuating the lipopolysaccharide (LPS) + Aβ-induced increase in IL-1β.Results PEG-PEI concentration less than 20 μg/ml and the N/P (molar ratio of PEG-PEI amino/siRNA phosphate) ratio of PPSR less than 50 showed no significant cytotoxicity in primary microglia cells. PPSR could effectively inhibit the expression of ROCK2 in primary microglial cells. A further study revealed that PPSR attenuates the LPS+Aβ-induced increase in IL-1β without affecting cell viability. In addition, we found that PPSR suppressed the Aβ-induced NLRP3/caspase 1 pathway in primary microglial cells. ConclusionPPSR inhibits Aβ 42 -induced microglial inflammation via NLRP3/caspase 1 pathway. NeuroReport

Actinobacillus pleuropneumoniae infection activates IL-1β expression in porcine alveolar macrophage by promoting β-amyloid production

“…Although the major isoform is Aβ40, Aβ42 exhibits stronger toxicity [27]. Previous studies showed that Aβ42 induces in ammatory cytokine generation [28,29]. In the present study we focused on the production of Aβ42 in cells during A. pleuropneumoniae infection.…”

What Is the Role of the Rho-ROCK Pathway in Neurologic Disorders?

“…103 Inhibition of ROCK2 improves traffic of APP and β-secretease to lysosomes 78 ; promotes autophagy of toxic Aβ oligomers 10 ; and protects against Aβ42-induced neurotoxicity, 104 apoptosis, 105 and microglial inflammation. 106 ROCK2 inhibitors also reduced levels of phosphorylated tau 107 and its accumulation into oligomers. 63 A study in a mouse AD model showed a tau-dependent reduction of micro RNA miR-135a-5p impaired synaptic activity in hippocampal neurons by promoting excessive ROCK2-mediated phosphorylation of adducin 1, which affects actin dynamics.…”

Neuroprotective effects and possible mechanisms of berberine in animal models of Alzheimer’s disease: a systematic review and meta-analysis

“…Early in plaque formation, Aβ produced by APP cleavage forms aggregates, and these aggregates cause phagocytosis by microglia, which releases a variety of proinflammatory cytokines as well as neurotoxic substances, including NO, IL-1β, IL-6, TNF-α, etc. These cytokines recruit more microglia Frontiers in Pharmacology frontiersin.org into amyloid plaques and they are urged to release more harmful Aβ, leading to amyloid plaque growth (Liu et al, 2022). In addition, astrocytes are also capable of responding to inflammatory signals and promoting inflammation (Meda et al, 2001).…”